| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/15/2009 | CN100478341C Voriconazole derivate and preparation process thereof |
| 04/14/2009 | US7517998 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus |
| 04/14/2009 | US7517994 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/14/2009 | US7517992 (-)-cis-1-(5-(4-fluorophenoxy)-pyridin-2-yl)-3-(4,7-difluoro-1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea; improved resistance and pharmacokinetic profile; polymerase inhibitors; potent against virus comprising drug escape mutations |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/14/2009 | US7517982 Naphthols useful for preparing indeno-fused photochromic naphthopyrans |
| 04/14/2009 | US7517903 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indole-4-one (CBI) with incorporated alkylating domain; in vivo drug-cleavable substrate conjugates that are potent cytotoxins; antiproliferative, anticarcinogenic agent; leukemia; bone marrow and mucosal toxicity; chronic cardiac and neurological toxicity |
| 04/14/2009 | US7517902 1-[4-(3-amino-7-fluoro-1H-indazol-6-yl)phenyl]-3-(2-fluoro-5-trifluoromethyl-phenyl)urea; protein kinases (Vascular Endothelial Growth Factor Receptor 2 and Tie-2), inhibitor; anticarcinogenic, antiinflammatory agent; neovascularization, lung and breast cancer, rheumatoid arthritis |
| 04/14/2009 | US7517900 Pyrazole derivatives as cannabinoid receptor modulators |
| 04/14/2009 | US7517898 2-tert-Butyl-N,N-diethyl-1-{[1-methylpiperidin-2-yl]methyl}-1H-benzimidazole-5-carboxamide; cannabinoid receptors agonists; analgesic, anticarcinogenic, antiinflammatory, anxiolytic agent; neurodegenerative diseases; gastrointestinal and cardiovascular disorders |
| 04/14/2009 | US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 04/14/2009 | US7517878 For example, 2-([3-tert-butyl-1-(2-methylphenyl)-1H-pyrazol-5-yl]amino)-6-methylnicotinic acid; compounds stimulate insulin secretion in the presence of glucose |
| 04/14/2009 | US7517877 5-substituted-alkylaminopyrazole derivatives as pesticides |
| 04/14/2009 | US7517875 Piperidine derivatives having CCR3 antagonism |
| 04/14/2009 | US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 04/14/2009 | CA2417050C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2385863C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/14/2009 | CA2256007C Substituted heterocyclic benzocycloalkenes and their use as analgesic |
| 04/14/2009 | CA2138533C Drugs that enhance synaptic responses mediated by ampa receptors |
| 04/09/2009 | WO2009044162A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
| 04/09/2009 | WO2009043780A1 Tetrazole-substituted aryl amide derivatives and uses thereof |
| 04/09/2009 | WO2009016218A3 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives |
| 04/09/2009 | WO2009003868A3 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
| 04/09/2009 | WO2008152093A3 Diaminopyrimidines as modulators of the ep2 receptor |
| 04/09/2009 | WO2008151927A3 6-n-substituted benz imidazole derivatives as acid pump antagonists |
| 04/09/2009 | WO2008148867A3 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 04/09/2009 | WO2008114272A3 Process for preparing alpuzosin and crystalline alfuzosin hydrochloride |
| 04/09/2009 | WO2008074997A8 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 04/09/2009 | WO2005086873A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 04/09/2009 | US20090093623 4,7-dichlororhodamine dyes |
| 04/09/2009 | US20090093531 Co-Solvent Compositions and Methods for Improved Delivery of Dantrolene Therapeutic Agents |
| 04/09/2009 | US20090093498 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5-dihydro-4H-imidazol-4-one |
| 04/09/2009 | US20090093494 4-Pyrimidineamine Compounds And Uses As Anti-Proliferative Agents |
| 04/09/2009 | US20090093485 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases |
| 04/09/2009 | US20090093479 Anti-cancer agents and uses thereof |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093462 3-Arylamino pyridine derivatives |
| 04/09/2009 | US20090093453 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| 04/09/2009 | US20090093416 Caspase inhibitors and uses thereof |
| 04/09/2009 | US20090091240 Compound containing fused ring and organic electroluminescent element employing the same |
| 04/09/2009 | DE4448032B4 Zusammensetzung enthaltend organische Materialien und 3-Aryl-benzofuranone als Stabilisatoren A composition comprising organic materials and 3-aryl-benzofuranones as stabilizers |
| 04/09/2009 | DE102007047738A1 Imidazolderivate Imidazole derivatives |
| 04/09/2009 | CA2738980A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
| 04/09/2009 | CA2701214A1 Tetrazole-substituted aryl amide derivatives and uses thereof |
| 04/09/2009 | CA2701114A1 Production of monatin stereoisomers |
| 04/09/2009 | CA2700530A1 Antifungal agents |
| 04/08/2009 | EP2045245A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 04/08/2009 | EP2045242A1 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/08/2009 | EP2044958A2 Pharmaceutical composition for treating arteriosclerosis |
| 04/08/2009 | EP2044073A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 04/08/2009 | EP2044060A1 Fungicide hydroximoyl-tetrazole derivatives |
| 04/08/2009 | EP2044059A1 2,5-disubstituted piperidines |
| 04/08/2009 | EP2044056A1 Pyrimidine derivatives as alk-5 inhibitors |
| 04/08/2009 | EP2044051A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
| 04/08/2009 | EP2044038A2 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 04/08/2009 | EP2044028A2 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif) |
| 04/08/2009 | EP2044019A1 3-oxoisoindoline-1-carboxamide derivatives as analgesic agents |
| 04/08/2009 | EP2043993A2 Cyclopentane derivatives as antiglaucoma agents |
| 04/08/2009 | EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/08/2009 | EP1606251B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 04/08/2009 | EP1551830B1 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibators |
| 04/08/2009 | EP1513811B1 Non-peptidic brs-3 agonists |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | CN101405283A HIV inhibiting 5-amido substituted pyrimidines |
| 04/08/2009 | CN101405281A Inhibitors of the interaction between MDM2 and P53 |
| 04/08/2009 | CN101405275A Triazolone derivative |
| 04/08/2009 | CN101405274A Polynuclear complex and polymer thereof |
| 04/08/2009 | CN101405265A Amido compounds and their use as pharmaceuticals |
| 04/08/2009 | CN101405263A Cannibinoid receptor modulators |
| 04/08/2009 | CN101402631A Amino quinazoline 2-maleate, production method and uses thereof |
| 04/08/2009 | CN101402623A 3-substituted benzene phthalein compounds with biological activity |
| 04/08/2009 | CN101402601A Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/08/2009 | CN100475793C Quinazoline derivatives and use for preparing medicine |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/07/2009 | US7514570 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |
| 04/07/2009 | US7514558 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary disease; asthma |
| 04/07/2009 | US7514461 Chroman derivatives |
| 04/07/2009 | US7514458 Heterocyclic-substituted benzamide derivatives, e.g., benzyl [2-(4-{1-[5-(5-tert-Butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazol-4-yl}-2-phenyl-2H-pyrazol-3-yl)-ethyl]-carbamate; inhibit production of cytokines; useful for treating chronic inflammatory disease |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514452 3-(4-hexylphenyl)-2-furancarboxylic acid 2-(4-hydroxy-3-nitrobenzoyl)hydrazide; nonpeptidergic glucagon receptor antagonist; orally; decrease blood sugar levels; hypoglycemic agent; dabetes mellitus type I and II, obesity, hyperlipidemia, gastrointestinal disorders |
| 04/07/2009 | US7514446 antineoplastic/antimitotic agents; inhibit proliferation of the cell; breast cancer, colon cancer, lung cancer, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma; Polo-like kinase inhibitors; 2-({5-nitro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid hydrochloride |
| 04/07/2009 | US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors) |
| 04/07/2009 | US7514439 Oxime derivative and preparations thereof |
| 04/07/2009 | US7514432 5-[5-(Benzo[b]thiophen-7-yloxy)-pentyloxy]-2-(tetrahydro-pyran-2-yloxymethyl)-4H-pyran-4-one; antiproliferative and antiangiogenic activities; to treat cancers (such as leukemia), ocular diseases and arthritis; excellent bioavailability and pharmacokinetic properties |
| 04/07/2009 | US7514429 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 04/07/2009 | US7514428 Pesticidal 1-aryl-3-amidoxime-pyrazole derivatives |
| 04/07/2009 | US7514424 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, visceral pain, neurogenic inflammation, asthma, micturition disorders such as urinary incontinence and nociception; reductive hydrogenation |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | CA2393757C Cycloamine ccr5 receptor antagonists |
| 04/07/2009 | CA2383583C Benzopyran derivative |
| 04/07/2009 | CA2373880C Isoquinoline derivatives or salts thereof |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/07/2009 | CA2358940C Method of producing thiobarbituric acid derivatives |
| 04/07/2009 | CA2352505C Epothilone derivatives and their use as antitumor agents |